References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30
- Houston KA, Henley SJ, Li J, et al. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009. Lung Cancer 2014;86:22-8
- SEER. SEER*Explorer. www.seer.cancer.gov. Accessed January 19, 2018
- NCCN. NCCN clinical practice guidelines in oncology: non-small cell lung cancer ver 8. NCCN; 2017, Available at nccn.org, Accessed January 19, 2018
- Hess LM, Cui ZL, Xiaohong L, et al. Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States from 2014–2017. Lung Cancer (submitted 2017)
- Bach PB, Conti RM, Muller RJ, et al. Overspending driven by oversized single dose vials of cancer drugs. BMJ 2016;352:i788
- Dooley MJ, Singh S, Michael M. Implications of dose rounding of chemotherapy to the nearest vial size. Support Care Cancer 2004;12:653-6
- Calvert AH, Newell DR, Gumbrell LA, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989;7:1748-56
- Field K, Zelenko A, Kosmider S, et al. Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs. Asia-Pacific J Clin Oncol 2010;6:203-9
- RED BOOK. Micromedex Clinical Knowledge Suite. Truven Health Analytics, an IBM Company; 2017. Available from: https://truvenhealth.com/products/micromedex/product-suites/clinical-knowledge/red-book
- Patel S, Le A. Rounding rituximab dose to nearest vial size. J Oncol Pharm Pract 2013;19:218-21
- Clark L, Castro AP, Fortes AF, et al. Ideal vial size for bortezomib: real-world data on waste and cost reduction in treatment of multiple myeloma in Brazil. Value Health 2011;14(5 Suppl 1):S82-4
- Sheffield KM, Beyrer J, Watson I, et al. Minimization of olaratumab drug waste using real-world data. Am J Health Syst Pharm 2017;74(11):832-842
- Leung CYW, Cheung MC, Charbonneau LF, et al. Financial impact of cancer drug wastage and potential cost savings from mitigation strategies. J Oncol Pract 2017;13:e646-e652